| 2019 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of … MM Ward, A Deodhar, LS Gensler, M Dubreuil, D Yu, MA Khan, N Haroon, ... Arthritis & rheumatology 71 (10), 1599-1613, 2019 | 871 | 2019 |
| Epidemiology of axial spondyloarthritis: an update R Wang, MM Ward Current opinion in rheumatology 30 (2), 137-143, 2018 | 197 | 2018 |
| Progression of nonradiographic axial spondyloarthritis to ankylosing spondylitis: a population‐based cohort study R Wang, SE Gabriel, MM Ward Arthritis & rheumatology 68 (6), 1415-1421, 2016 | 104 | 2016 |
| Comparative efficacy of non-steroidal anti-inflammatory drugs in ankylosing spondylitis: a Bayesian network meta-analysis of clinical trials R Wang, A Dasgupta, MM Ward Annals of the rheumatic diseases 75 (6), 1152-1160, 2016 | 99 | 2016 |
| Syndesmophyte growth in ankylosing spondylitis S Tan, R Wang, MM Ward Current opinion in rheumatology 27 (4), 326-332, 2015 | 66 | 2015 |
| Risk of adverse outcomes in hospitalized patients with autoimmune disease and COVID-19: a matched cohort study from New York City AS Faye, KE Lee, M Laszkowska, J Kim, JW Blackett, AS McKenney, ... The Journal of rheumatology 48 (3), 454-462, 2021 | 33 | 2021 |
| Comparative efficacy of tumor necrosis factor-α inhibitors in ankylosing spondylitis: a systematic review and Bayesian network metaanalysis R Wang, A Dasgupta, MM Ward The Journal of rheumatology 45 (4), 481-490, 2018 | 29 | 2018 |
| Clinical evolution in patients with new‐onset inflammatory back pain: a population‐based cohort study R Wang, CS Crowson, K Wright, MM Ward Arthritis & Rheumatology 70 (7), 1049-1055, 2018 | 24 | 2018 |
| Nonsteroidal antiinflammatory drugs as potential disease‐modifying medications in axial spondyloarthritis R Wang, JM Bathon, MM Ward Arthritis & Rheumatology 72 (4), 518-528, 2020 | 22 | 2020 |
| Predicting probability of response to tumor necrosis factor inhibitors for individual patients with ankylosing spondylitis R Wang, A Dasgupta, MM Ward JAMA Network Open 5 (3), e222312-e222312, 2022 | 18 | 2022 |
| Targeting the interleukin-23/interleukin-17 inflammatory pathway: successes and failures in the treatment of axial spondyloarthritis R Wang, WP Maksymowych Frontiers in Immunology 12, 715510, 2021 | 16 | 2021 |
| Arthritis of the spine R Wang, MM Ward Spinal Imaging and Image Analysis, 31-66, 2014 | 6 | 2014 |
| Gout increases length of stay in patients hospitalized for heart failure exacerbation D DeMizio, G Wu, Y Wei, J Bathon, R Wang Therapeutic Advances in Musculoskeletal Disease 14, 1759720X221102853, 2022 | 4 | 2022 |
| Response to:‘Heterogeneity, consistency and model fit should be assessed in Bayesian network meta-analysis’ by Wei et al MM Ward, A Dasgupta, R Wang Annals of the rheumatic diseases 75 (1), e6-e6, 2016 | 1 | 2016 |
| Predicting Major Treatment Response to Tumor Necrosis Factor Inhibitorsin Patients with Ankylosing Spondylitis R Wang, A Dasgupta, M Ward ARTHRITIS & RHEUMATOLOGY 72, 2020 | | 2020 |
| Low rate of progression to ankylosing spondylitis among patients with presumed nonradiographic axial spondyloarthritis: comment on the article by Wang et al Reply R Wang, MM Ward ARTHRITIS & RHEUMATOLOGY 69 (3), 677-678, 2017 | | 2017 |
